Top
Main

All outcomes

Feedback
Home
Show Outline
Top   Main   All Outcomes
Home   COVID-19 treatment studies for Sleep  COVID-19 treatment studies for Sleep  C19 studies: Sleep  Sleep   Select treatmentSelect treatmentTreatmentsTreatments
Antiandrogens (meta) Lactoferrin (meta)
Aspirin (meta) Melatonin (meta)
Bamlaniv../e.. (meta) Metformin (meta)
Bebtelovimab (meta) Molnupiravir (meta)
Bromhexine (meta) N-acetylcys.. (meta)
Budesonide (meta) Nigella Sativa (meta)
Cannabidiol (meta) Nitazoxanide (meta)
Casirivimab/i.. (meta) Paxlovid (meta)
Colchicine (meta) Peg.. Lambda (meta)
Conv. Plasma (meta) Povidone-Iod.. (meta)
Curcumin (meta) Probiotics (meta)
Diet (meta) Proxalutamide (meta)
Ensitrelvir (meta) Quercetin (meta)
Ensovibep (meta) Remdesivir (meta)
Exercise (meta) Sleep (meta)
Famotidine (meta) Sotrovimab (meta)
Favipiravir (meta) Tixagev../c.. (meta)
Fluvoxamine (meta) Vitamin A (meta)
Hydroxychlor.. (meta) Vitamin C (meta)
Iota-carragee.. (meta) Vitamin D (meta)
Ivermectin (meta) Zinc (meta)

Other Treatments Global Adoption
Loading...
Antiandrogens
Aspirin
Bromhexine
Budesonide
Cannabidiol
Casirivimab/i..
Colchicine
Conv. Plasma
Curcumin
Diet
Ensovibep
Exercise
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Melatonin
Metformin
Molnupiravir
Nigella Sativa
Nitazoxanide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Proxalutamide
Quercetin
Remdesivir
Sleep
Sotrovimab
Vitamin A
Vitamin C
Vitamin D
Zinc
Supplementary Data — Sleep for COVID-19: real-time meta analysis of 7 studies
Covid Analysis, May 22, 2022, DRAFT
https://c19early.com/slmeta.html
0 0.25 0.5 0.75 1 1.25 1.5 1.75 2+ Holt 12% 0.88 [0.61-1.27] cases n/a n/a Improvement, RR [CI] Treatment Control Holt 12% 0.88 [0.68-1.14] cases n/a n/a Holt 22% 0.78 [0.60-0.99] cases n/a n/a Marcus 16% 0.84 [0.76-0.93] symp. case n/a n/a Li 43% 0.57 [0.35-0.90] death n/a n/a Li 36% 0.64 [0.46-0.89] hosp. n/a n/a Li 21% 0.79 [0.64-0.96] hosp. n/a n/a Mohsin 38% 0.62 [0.49-0.77] severe case 327/948 273/552 Huang 81% 0.19 [0.05-0.66] severe case 12/127 4/9 Kim 17% 0.83 [0.70-0.99] m/s case n/a n/a Kim 11% 0.89 [0.81-0.97] cases n/a n/a Paul 67% 0.33 [0.19-0.55] no recov. n/a n/a Paul 54% 0.46 [0.28-0.74] no recov. n/a n/a sleep COVID-19 outcomes c19early.com/sl May 2022 Favors good sleep Favors control
Figure S1. All outcomes.
Please send us corrections, updates, or comments. Vaccines and treatments are both valuable and complementary. All practical, effective, and safe means should be used. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. Denying the efficacy of any method increases mortality, morbidity, collateral damage, and the risk of endemic status. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit